Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Saturday, June 30, 2018

REVAMP - Its Here!!

And its called REVAMP (re-valuing antimicrobial products). This bill, proposed in the US House of Representatives by Rep John Shimku...

Friday, June 15, 2018

Gottlieb and FDA to the Rescue

This week, Scott Gottieb, our FDA Commissioner, stated that he was examining, along with the Center for Medicare and Medicaid Services (C...

Monday, June 11, 2018

REVIVE: open access to knowledge and resources for the antimicrobial R&D community

GUEST BLOGGER - Laura Piddock - Head of Scientific Affairs, Global Research and Development Partnership (GARDP). webinar June 13!!!...

Wednesday, June 6, 2018

Urgent - Time to Act!

For those of you who have not been following this story closely, the market entry rewards we have been discussing that are intended to fix...

Friday, June 1, 2018

Allergan Bails!

NEW FLASH! I hate being right when it comes to pharmaceutical companies abandoning antibiotic R&D. But Allergan just announce...

Sunday, May 27, 2018

Paul Krugman, Nabriva and the Antibiotics Market

What does Paul Krugman, the Nobel Laureate in economics and New York Times columnist have to do with Nabriva and antibiotics? While I d...

Monday, May 7, 2018

Standard of Care Antibiotics?

One of the major arguments against the use of superiority trials for antibiotics goes as follows. Once a new antibiotic has been shown to b...

View web version

Powered by Blogger.